Zacks Investment ResearchThu, 07 May 2026 16:35:12 GMTMadrigal Q1 Earnings Beat, MASH Drug Sales Drive Top Line, Stock UpMDGL-3.62%
Seeking AlphaWed, 06 May 2026 18:01:20 GMTMadrigal Pharmaceuticals, Inc. (MDGL) Q1 2026 Earnings Call TranscriptMDGL-3.62%
Zacks Investment ResearchWed, 06 May 2026 13:25:26 GMTMadrigal (MDGL) Reports Q1 Loss, Beats Revenue EstimatesMDGL-3.62%
24/7 Wall StreetSun, 03 May 2026 13:30:31 GMT3 Biotech Stocks to Watch for Respectable Growth Beyond AIMDGL-3.62%
Zacks Investment ResearchThu, 30 Apr 2026 15:06:24 GMTAnalysts Estimate Crinetics Pharmaceuticals, Inc. (CRNX) to Report a Decline in Earnings: What to Look Out forMDGL-3.62%
Zacks Investment ResearchWed, 29 Apr 2026 15:01:21 GMTMadrigal (MDGL) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 ReleaseMDGL-3.62%
Seeking AlphaTue, 28 Apr 2026 18:27:46 GMTMadrigal Pharmaceuticals: Boom Or Bust In MASH? Regretfully, I'm BearishMDGL-3.62%
The Motley FoolThu, 16 Apr 2026 21:45:00 GMT3 Under-the-Radar Healthcare Stocks Worth Adding to Your WatchlistMDGL-3.62%
Zacks Investment ResearchFri, 27 Mar 2026 14:06:10 GMTMadrigal (MDGL) Surges 12.3%: Is This an Indication of Further Gains?MDGL-3.62%
The Motley FoolWed, 25 Mar 2026 21:24:00 GMTPrediction: 2 Stocks That Will Be Worth More Than Summit Therapeutics 1 Year From NowMDGL-3.62%